Immunity to Infection in Healthy Participants and Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- N/A
Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.
- Status
- UNKNOWN
- Phase
- NA
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children
- Status
- UNKNOWN
- Phase
- PHASE3
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
- Status
- COMPLETED
- Phase
- NA
DMID 21-0041; Influenza CVD 59000
- Status
- COMPLETED
- Phase
- NA
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months
- Status
- COMPLETED
- Phase
- PHASE3
Bone Marrow and Peripheral Blood Immune Responses Study
- Status
- RECRUITING
- Phase
- PHASE4
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
- Status
- RECRUITING
- Phase
- NA
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
- Status
- UNKNOWN
- Phase
- N/A
Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1
Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults
- Status
- RECRUITING
- Phase
- N/A
Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin
- Status
- COMPLETED
- Phase
- PHASE1